LeMaitre Vascular LMAT
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 3rd percentile, 5-year average 45.5x
#2086 of 2993 stocks by PE (1 = cheapest)
Below its usual level · 22nd percentile, 5-year average 5.0x
#4174 of 5330 stocks by PB (1 = cheapest)
Below its usual level · 34th percentile, 5-year average 7.9x
#4230 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 4.15 | – | 5.00 | 22% (cheaper than usual) | #4174 of 5330 (1 = cheapest) |
| PE | 28.47 | 25.02 | 45.51 | 3% (cheaper than usual) | #2086 of 2993 (1 = cheapest) |
| PS | 7.05 | 6.38 | 7.91 | 34% (cheaper than usual) | #4230 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on LMAT.
Sign in to join the discussion.